"We have been working diligently for months to build ample supply, with doses ready to ship in time for the fall vaccination season in the Northern Hemisphere,” Moderna's CEO said in the announcement.

Cardiovascular Associates of America, which has already had an eventful 2023, announced a new acquisition that helps expand its footprint in the Sunshine State. 

The modality switch became especially important during the iodinated contrast shortage of 2022 when clinics were forced to deploy mitigation tactics as a means of preserving their contrast supply. 

Diagnosing, treating and managing aortic stenosis is often a challenging task, especially when the patient has a long life expectancy. Shared decision-making can make a significant impact, helping ensure the patient's values and preferences are taken into consideration. 

The FDA Circulatory System Devices Panel is set to review the PMA submissions for the ReCor and Medtronic renal denervation systems to treat patients with uncontrolled hypertension.

Anumana, Pfizer and Mayo Clinic all worked together to develop the advanced algorithm. The groups are now targeting full regulatory approval in the U.S., Europe and Japan.

Did your facility make the cut? For its 2023-2024 list, U.S. News and World Report evaluated data from 119 hospitals and surveyed thousands of pediatric specialists.

The new-look DCB was designed to provide care with a significantly lower drug load than similar devices.